Monday, September 28, 2009

Abbott to buy Solvay drug business for up to $7 billion - MarketWatch


TopNews United States

Abbott to buy Solvay drug business for up to $7 billion
MarketWatch
LONDON (MarketWatch) -- Abbott Laboratories said Monday that it will buy the pharmaceuticals business of Belgium's Solvay for ...
US-BUSINESS SummaryWashington Post
PRESS DIGEST - New York Times business news - Sept 28Reuters
Abbott Gets Belgian Drug Unit for $7.6 BillionNew York Times
Wall Street Journal -Bloomberg -New York Times
all 279 news articles »

No comments:

Post a Comment